News
How Is The Market Feeling About Altimmune?
8 Apr 24
Short Sellers, Short Ideas, Trading Ideas
If You Invested $100 In This Stock 5 Years Ago, You Would Have $300 Today
3 Apr 24
News, Trading Ideas
HC Wainwright & Co. Maintains Buy on Altimmune, Lowers Price Target to $12
1 Apr 24
News, Price Target, Analyst Ratings
Why Kodiak Sciences Shares Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
28 Mar 24
News, Penny Stocks, Small Cap, Intraday Update, Markets, Movers, Trading Ideas
Why Is Obesity Drug Developer Altimmune Stock Trading Lower On Wednesday?
27 Mar 24
Biotech, Earnings, News, Guidance, Health Care, Movers, General
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
27 Mar 24
Movers
Altimmune Q4 GAAP EPS $(0.54) Misses $(0.43) Estimate, Sales $37.00K Up From $(110.00K) YoY
27 Mar 24
Earnings, News
Earnings Scheduled For March 27, 2024
27 Mar 24
Earnings
Altimmune's Earnings Outlook
26 Mar 24
Earnings
(ALT) - Analyzing Altimmune's Short Interest
22 Mar 24
Short Sellers, Short Ideas, Trading Ideas
Cramer Calls Datadog 'Dynamite,' Puts SoFi In Dog House: 'What The Heck Is Going On'
19 Mar 24
Long Ideas, News, Small Cap, Top Stories, Markets, Media, Trading Ideas
Here's How Much $100 Invested In Altimmune 5 Years Ago Would Be Worth Today
18 Mar 24
News, Trading Ideas
Here's How Much $100 Invested In Altimmune 5 Years Ago Would Be Worth Today
28 Feb 24
News, Trading Ideas
Why Helix Energy Solutions Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
27 Feb 24
News, Penny Stocks, Small Cap, Intraday Update, Markets, Movers, Trading Ideas
Why Freshpet Shares Are Trading Higher By Around 15%? Here Are Other Stocks Moving In Monday's Mid-Day Session
26 Feb 24
News, Penny Stocks, Small Cap, Intraday Update, Markets, Movers, Trading Ideas
Altimmune Stock Surges, Kerrisdale Remains Short: What You Need To Know
26 Feb 24
News, Short Sellers, Movers
12 Health Care Stocks Moving In Monday's Pre-Market Session
26 Feb 24
Movers
(ALT) - Analyzing Altimmune's Short Interest
14 Feb 24
Short Sellers, Short Ideas, Trading Ideas
B. Riley Securities Maintains Buy on Altimmune, Announces $20 Price Target
13 Feb 24
News, Price Target, Analyst Ratings
Altimmune Stock Sinks As Kerrisdale Capital Announces Short Position: 'Obvious Dead End'
13 Feb 24
Press releases
Thinking about buying stock in Ocugen, Ceragon Networks, Gannett, Altimmune, or Nio?
1 Apr 24
Opinion, Press Releases
Altimmune Announces Positive Lean Mass Preservation Data for Pemvidutide and Reports Fourth Quarter and Full Year 2023 Financial Results
27 Mar 24
Earnings, Press Releases
Altimmune to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on March 27, 2024
20 Mar 24
News, Press Releases
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Altimmune, Inc. - ALT
7 Mar 24
News, Legal, Press Releases
ROSEN, A LONGSTANDING LAW FIRM, Encourages Altimmune, Inc. Investors to Inquire About Securities Class Action Investigation - ALT
5 Mar 24
Press Releases
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Altimmune, Inc. - ALT
3 Mar 24
Press Releases
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Altimmune, Inc. - ALT
28 Feb 24
News, Legal, Press Releases
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Altimmune, Inc. Investors to Inquire About Securities Class Action Investigation – ALT
28 Feb 24
News, Legal, Press Releases
Thinking about buying stock in Intuitive Machines, SoundHound AI, Interactive Strength, Altimmune, or NanoVibronix?
26 Feb 24
Small Cap, Opinion, Press Releases
Altimmune, Inc. (ALT) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
26 Feb 24
Press Releases
ROSEN, A TOP RANKED LAW FIRM, Encourages Altimmune, Inc. Investors to Inquire About Securities Class Action Investigation - ALT
25 Feb 24
Press Releases
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Altimmune, Inc. Investors to Inquire About Securities Class Action Investigation – ALT
24 Feb 24
News, Legal, Press Releases
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Altimmune, Inc. - ALT
24 Feb 24
Press Releases
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Altimmune, Inc. - ALT
20 Feb 24
News, Legal, Press Releases
NATIONALLY RANKED ROSEN LAW FIRM Encourages Altimmune, Inc. Investors to Inquire About Securities Class Action Investigation – ALT
19 Feb 24
News, Legal, Press Releases
ROSEN, LEADING INVESTOR COUNSEL, Encourages Altimmune, Inc. Investors to Inquire About Securities Class Action Investigation - ALT
16 Feb 24
Press Releases
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Altimmune, Inc. - ALT
15 Feb 24
Press Releases
ROSEN, A TOP RANKED LAW FIRM, Encourages Altimmune, Inc. Investors to Inquire About Securities Class Action Investigation – ALT
14 Feb 24
Press Releases
Thinking about trading options or stock in Amazon, Eli Lilly, Altimmune, Novavax, or Snap?
12 Feb 24
Opinion, Press Releases